Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired shares of Syneos Health (NASDAQ:SYNH) (formerly INC Research Holdings, Inc. (NASDAQ:INCR)) between May 10, 2017 and November 9, 2017 (the “Class Period”). Investors have until January 30, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose: (1) that the Merger was not providing the benefit that Defendants stated it would; (2) that inVentiv was underperforming; (3) that, as a result, the Company's 2017 financial performance would be negatively impacted; and (4) that, as a result of the foregoing, Defendants’ statements about INC Research's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
If you purchased or otherwise acquired INC Research securities and suffered a loss, continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning the INC Research Holdings, Inc. lawsuit, please go to http://www.bespc.com/INCR. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.